HRI Senior Scientist, Dr. James MacKillop, has received $491,000 from the Canadian Institutes of Health Research (CIHR) for a study that will examine the impact of COVID-19 on mental health and substance use.Read More “New funding will support research exploring impact of COVID-19 on mental health”
Treatment of alcohol use disorder is multi-faceted and often includes participation in mutual-support groups, the oldest and largest of which is Alcoholics Anonymous (AA).
Although frequent AA meeting attendance is associated with greater abstinence from alcohol, there is little understanding of the specific mechanisms by which AA benefits people. In other words, we know that AA works, but we aren’t sure how.Read More “International study explores how AA contributes to recovery”
The CBD industry is booming. CBD (short for cannabidiol) is a chemical compound derived from the cannabis plant that is marketed as a cure-all and added to everything from bath bombs to dog treats.
But has the hype of CBD gotten ahead of the science?Read More “Exploring the use of CBD in treating alcohol use disorder”
As Canada enters its second month following the nationwide legalization of cannabis, Dr. James MacKillop, HRI Senior Scientist and Director of the Peter Boris Centre for Addictions Research and the Michael G. DeGroote Centre for Medicinal Cannabis Research, is encouraging Canadians to think critically about cannabis use.Read More “HRI Senior Scientist contributes to national discussions on the legalization of cannabis”
Military members and veterans are among those most vulnerable to post-traumatic stress disorder (PTSD). There is an urgent need to identify new and innovative treatments that will help military members suffering from trauma-related illnesses.Read More “Advancing research for military and veteran mental health”
Addiction and post-traumatic stress disorder (PTSD) often occur together, causing debilitating consequences for those affected. There is little consensus among clinicians about how best to treat individuals suffering from both disorders, but new research is providing hope for patients and healthcare providers alike. This will be the focus of an upcoming symposium.Read More “Upcoming symposium on addiction and PTSD”
Recovery from addiction can mean different things to different people. A recent publication by HRI Research and Evaluation Scientist, Dr. Jean Costello, highlights the importance of incorporating insights from people with lived experience when building systems for measuring treatment success.Read More “Promoting patient-oriented research”
Since 2015, Homewood Research Institute (HRI) has partnered with Homewood Health Centre to collect data from patients who receive treatment in the Centre’s Addiction Medicine Service (AMS).Read More “Multi-year research study sheds light on addiction recovery”
HRI research findings were featured in three presentations at a national conference hosted in Calgary, Alberta by the Canadian Centre on Substance Use and Addiction (CCSA) in November. The Issues of Substance Conference brings together addiction experts, policy makers and researchers to mobilize knowledge in the addiction field to address substance use in Canada. HRI was pleased to share updates and findings from three major projects currently underway.Read More “HRI research findings featured at national addiction conference”
HRI has created an infographic summarizing early findings from the Post-Discharge Outcomes Monitoring System (PDO), also known to Homewood patients as the Recovery Journey Project.Read More “Infographic: A closer look at the recovery journey”